المؤلفون: Los-de Vries GT; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Stathi P; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Rutkens R; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Hijmering NJ; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Luijks JACW; Department of Pathology, RadboudUMC Nijmegen, Nijmegen, the Netherlands., Groenen PJTA; Department of Pathology, RadboudUMC Nijmegen, Nijmegen, the Netherlands., de Jong D; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Ylstra B; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Roemer MGM; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.

المصدر: Cancer research [Cancer Res] 2023 Jun 02; Vol. 83 (11), pp. 1917-1927.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Precursor Cells, B-Lymphoid*/pathology , Lymphoma, Large B-Cell, Diffuse*/genetics, Male ; Humans ; Neoplasm Recurrence, Local/genetics ; Mutation ; Clonal Evolution/genetics

المؤلفون: Stevens WBC; Department of Hematology, Radboud UMC Nijmegen, the Netherlands., Los-de Vries GT; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., Langois-Jacques C; Université Lyon 1, Villeurbanne, France.; CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France.; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France., Clear AJ; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom., Stathi P; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., Sander B; Division of Pathology, Department of Laboratory Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden., Rosenwald A; Institute of Pathology, University of Würzburg, Germany.; Comprehensive Cancer Center Mainfranken, Würzburg, Germany., Calaminici M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom., Hoster E; Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), LMU University, Munich, Germany.; Department of Medicine III, LMU University Hospital, Munich, Germany., Hiddemann W; Department of Medicine III, LMU University Hospital, Munich, Germany., Gaulard P; Department of Pathology, Henri Mondor University Hospital, APHP, INSERM U955, Université Paris-Est, Créteil, France., Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Klapper W; Institute of Pathology, University of Schleswig-Holstein, Kiel, Germany., Xerri L; Département de Biopathologie, Institut Paoli-Calmettes, Marseille, France., Burton C; Haematological Malignancy Diagnostic Service, St James University Hospital, Leeds, United Kingdom., Tooze RM; Division of Haematology & Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom., Smith AG; Epidemiology & Cancer Statistics Group, Department of Health Sciences, University of York, United Kingdom., Buske C; Institute of Experimental Cancer Research, CCC Ulm, Universitäts Klinikum Ulm, Germany., Scott DW; BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada., Natkunam Y; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford, CA, USA., Advani R; Stanford Cancer Institute, Stanford, CA, USA.; Department of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Sehn LH; BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada., Raemaekers J; Department of Hematology, Radboud UMC Nijmegen, the Netherlands., Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom., Lockmer S; Division of Hematology, Department of Medicine, Karolinska Institute, Stockholm, Sweden., Kimby E; Division of Hematology, Department of Medicine, Karolinska Institute, Stockholm, Sweden., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Center Amsterdam, the Netherlands., Maucort-Boulch D; Université Lyon 1, Villeurbanne, France.; CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France.; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France., Ylstra B; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., van Dijk E; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., de Jong D; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.

المصدر: HemaSphere [Hemasphere] 2023 Apr 05; Vol. 7 (4), pp. e863. Date of Electronic Publication: 2023 Apr 05 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Mendeville M; 1Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands., Roemer MGM; 1Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands., Los-de Vries GT; 1Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands., Chamuleau MED; Department of Haematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands., de Jong D; 1Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands., Ylstra B; 1Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands.

المصدر: Frontiers in oncology [Front Oncol] 2022 Oct 27; Vol. 12, pp. 970063. Date of Electronic Publication: 2022 Oct 27 (Print Publication: 2022).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Los-de Vries GT; Department of Pathology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Stevens WBC; Department of Hematology, Radboudumc Nijmegen, Nijmegen, The Netherlands., van Dijk E; Department of Pathology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Langois-Jacques C; Université Lyon 1, Villeurbanne, France, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de recherche (UMR) 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France.; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France., Clear AJ; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom., Stathi P; Department of Pathology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Roemer MGM; Department of Pathology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Mendeville M; Department of Pathology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Hijmering NJ; Department of Pathology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Sander B; Department of Laboratory Medicine, Division of Pathology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden., Rosenwald A; Institute of Pathology, University of Würzburg, Würzburg, and Comprehensive Cancer Center Mainfranken, Germany., Calaminici M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom., Hoster E; Department of Medicine III, University Hospital Grosshadern, Munich, Germany.; Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), LMU University, Munich, Germany., Hiddemann W; Department of Medicine III, University Hospital Grosshadern, Munich, Germany., Gaulard P; Department of Pathology, Henri Mondor University Hospital, Assistance Pyblique- Hospitaux de Paris (APHP), INSERM U955, Université Paris-Est, Créteil, France., Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Horn H; Institute for Clinical Pathology, Robert-Bosch-Krankenhaus, Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Stuttgart, Germany., Klapper W; Institute of Pathology, University of Schleswig-Holstein, Kiel, Germany., Xerri L; Département de Biopathologie, Institut Paoli-Calmettes, Marseille, France., Burton C; Haematological Malignancy Diagnostic Service, St. James University Hospital, Leeds, United Kingdom., Tooze RM; Division of Haematology & Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom., Smith AG; Epidemiology & Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom., Buske C; Institute of Experimental Cancer Research, Comprehensive Cancer Center (CCC) Ulm, Universitätsklinikum Ulm, Ulm, Germany., Scott DW; BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada., Natkunam Y; Department of Pathology, and., Advani R; Department of Hematology, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, CA., Sehn LH; BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada., Raemaekers J; Department of Hematology, Radboudumc Nijmegen, Nijmegen, The Netherlands., Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom., Kimby E; Department of Medicine, Division of Hematology, Karolinska Institute, Stockholm, Sweden; and., Kersten MJ; Department of Hematology, Amsterdam University Medical Center (UMC), University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Maucort-Boulch D; Université Lyon 1, Villeurbanne, France, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de recherche (UMR) 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France.; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France., Ylstra B; Department of Pathology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., de Jong D; Department of Pathology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.

المصدر: Blood advances [Blood Adv] 2022 Sep 27; Vol. 6 (18), pp. 5482-5493.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Follicular*/genetics, Genomics ; Histones/genetics ; Humans ; Programmed Cell Death 1 Receptor/metabolism ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Translocation, Genetic

المؤلفون: Allahyar A; Oncode Institute & Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Pieterse M; Oncode Institute & Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Swennenhuis J; Cergentis BV, Utrecht, the Netherlands., Los-de Vries GT; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, the Netherlands., Yilmaz M; Cergentis BV, Utrecht, the Netherlands., Leguit R; University Medical Centre Utrecht, Department of Pathology, Utrecht, the Netherlands., Meijers RWJ; University Medical Centre Utrecht, Department of Pathology, Utrecht, the Netherlands., van der Geize R; Laboratorium Pathologie Oost-Nederland, Hengelo, the Netherlands., Vermaat J; Leiden University Medical Centre, Department of Hematology, Leiden, the Netherlands., Cleven A; Leiden University Medical Center, Department of Pathology, Leiden, the Netherlands., van Wezel T; Leiden University Medical Center, Department of Pathology, Leiden, the Netherlands., Diepstra A; University of Groningen, University Medical Centre Groningen, Department of Pathology & Medical Biology, Groningen, the Netherlands., van Kempen LC; University of Groningen, University Medical Centre Groningen, Department of Pathology & Medical Biology, Groningen, the Netherlands., Hijmering NJ; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, the Netherlands., Stathi P; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, the Netherlands., Sharma M; Oncode Institute & Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Melquiond ASJ; Oncode Institute & Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., de Vree PJP; Oncode Institute & Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Verstegen MJAM; Oncode Institute & Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Krijger PHL; Oncode Institute & Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Hajo K; Cergentis BV, Utrecht, the Netherlands., Simonis M; Cergentis BV, Utrecht, the Netherlands., Rakszewska A; Cergentis BV, Utrecht, the Netherlands., van Min M; Cergentis BV, Utrecht, the Netherlands., de Jong D; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, the Netherlands., Ylstra B; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, the Netherlands., Feitsma H; Cergentis BV, Utrecht, the Netherlands., Splinter E; Cergentis BV, Utrecht, the Netherlands. erik.splinter@cergentis.com., de Laat W; Oncode Institute & Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands. w.laat@hubrecht.eu.

المصدر: Nature communications [Nat Commun] 2021 Jun 07; Vol. 12 (1), pp. 3361. Date of Electronic Publication: 2021 Jun 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Translocation, Genetic*, High-Throughput Nucleotide Sequencing/*methods , Lymphoma, B-Cell/*genetics , Lymphoma, Non-Hodgkin/*genetics , Paraffin Embedding/*methods , Tissue Fixation/*methods, Computational Biology/methods ; Gene Rearrangement ; Genes, bcl-2/genetics ; Genes, myc/genetics ; Humans ; In Situ Hybridization, Fluorescence/methods ; Lymphoma, B-Cell/diagnosis ; Lymphoma, Non-Hodgkin/diagnosis ; Proto-Oncogene Proteins c-bcl-6/genetics ; Reproducibility of Results ; Retrospective Studies ; Sensitivity and Specificity

المؤلفون: Los-de Vries GT; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Boer M; Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands., van Dijk E; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Stathi P; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Hijmering NJ; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Roemer MGM; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Mendeville M; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Miedema DM; LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Boer JP; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Rakhorst HA; Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente, Enschede, The Netherlands; and., van Leeuwen FE; Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Hulst RRWJ; Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands., Ylstra B; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Jong D; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

المصدر: Blood [Blood] 2020 Dec 17; Vol. 136 (25), pp. 2927-2932.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/etiology , Breast Neoplasms*/genetics , Breast Neoplasms*/metabolism , Breast Neoplasms*/pathology , Chromosome Deletion* , Chromosomes, Human, Pair 20*/genetics , Chromosomes, Human, Pair 20*/metabolism , Lymphoma, Large-Cell, Anaplastic*/etiology , Lymphoma, Large-Cell, Anaplastic*/genetics , Lymphoma, Large-Cell, Anaplastic*/metabolism , Lymphoma, Large-Cell, Anaplastic*/pathology , Mutation* , Neoplasm Proteins*/genetics , Neoplasm Proteins*/metabolism, Breast Implants/*adverse effects, Female ; Humans ; Retrospective Studies

المؤلفون: Mendeville M; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands., Roemer MGM; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands., van den Hout MFCM; Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; and., Los-de Vries GT; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands., Bladergroen R; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands., Stathi P; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands., Hijmering NJ; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands., Rosenwald A; Institute of Pathology, University of Würzburg and Comprehensive Cancer Center Mainfranken, Würzburg, Germany., Ylstra B; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands., de Jong D; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands.

المصدر: Blood [Blood] 2019 Jan 24; Vol. 133 (4), pp. 377-380. Date of Electronic Publication: 2018 Dec 03.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Genome, Human*, Herpesvirus 8, Human/*physiology , Lymphoma/*complications , Lymphoma/*genetics , Lymphoma, Primary Effusion/*complications , Lymphoma, Primary Effusion/*genetics, Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged

المؤلفون: Wang L; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Leite de Oliveira R; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Huijberts S; Division of Clinical Pharmacology, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Bosdriesz E; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Pencheva N; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Brunen D; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Bosma A; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Song JY; Division of Molecular Genetics, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Zevenhoven J; Division of Molecular Genetics, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Los-de Vries GT; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Horlings H; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Nuijen B; Department of Pharmacy and Pharmacology, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Schellens JHM; Division of Clinical Pharmacology, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. Electronic address: r.bernards@nki.nl.

المصدر: Cell [Cell] 2018 May 31; Vol. 173 (6), pp. 1413-1425.e14. Date of Electronic Publication: 2018 May 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Neoplasm*, Melanoma/*drug therapy , Skin Neoplasms/*drug therapy, Amino Acid Transport System y+/metabolism ; Animals ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; Gene Expression Regulation, Neoplastic/drug effects ; Histone Deacetylase Inhibitors/pharmacology ; Humans ; MAP Kinase Kinase 1/metabolism ; MAP Kinase Signaling System ; Melanoma/genetics ; Mice ; Mutation ; Neoplasm Transplantation ; Protein Kinase Inhibitors/pharmacology ; Proto-Oncogene Proteins B-raf/genetics ; Reactive Oxygen Species/metabolism ; Skin Neoplasms/genetics ; Treatment Outcome ; Vorinostat/pharmacology